{"id":"https://openalex.org/W76228501","doi":"https://doi.org/10.1007/bf03320656","title":"Analisi costo-efficacia dell\u2019associazione budesonide/formoterolo come terapia di mantenimento e \u201cal bisogno\u201d nella gestione dell\u2019asma. Valutazione italiana","display_name":"Analisi costo-efficacia dell\u2019associazione budesonide/formoterolo come terapia di mantenimento e \u201cal bisogno\u201d nella gestione dell\u2019asma. Valutazione italiana","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W76228501","doi":"https://doi.org/10.1007/bf03320656","mag":"76228501"},"language":"it","primary_location":{"id":"doi:10.1007/bf03320656","doi":"https://doi.org/10.1007/bf03320656","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf03320656","pdf_url":null,"source":{"id":"https://openalex.org/S2764875651","display_name":"PharmacoEconomics Italian Research Articles","issn_l":"1590-9158","issn":["1590-9158","2035-6137"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["anvur-scientific"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics Italian Research Articles","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032116339","display_name":"Carlo R. Lazzaro","orcid":"https://orcid.org/0000-0003-4795-1834","observed_orcids":["https://orcid.org/0000-0003-4795-1834"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"C. Lazzaro","raw_affiliation_strings":["Economista sanitario,\n        Milano, Italia","Milano, Italia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Economista sanitario,\n        Milano, Italia","institution_ids":[]},{"raw_affiliation_string":"Milano, Italia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025619708","display_name":"Pierfrancesco Ruffo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139728","display_name":"AstraZeneca (Italy)","ror":"https://ror.org/04e6qgn10","country_code":"IT","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210139728"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Ruffo","raw_affiliation_strings":["Pricing & Health Economic Affairs Dept., AstraZeneca S.p.A., Basiglio, Mi, Italy","AstraZeneca S.p.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pricing & Health Economic Affairs Dept., AstraZeneca S.p.A., Basiglio, Mi, Italy","institution_ids":["https://openalex.org/I4210139728"]},{"raw_affiliation_string":"AstraZeneca S.p.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045631939","display_name":"M. Gozzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139728","display_name":"AstraZeneca (Italy)","ror":"https://ror.org/04e6qgn10","country_code":"IT","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210139728"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Gozzo","raw_affiliation_strings":["Pricing & Health Economic Affairs Dept., AstraZeneca S.p.A., Basiglio, Mi, Italy","AstraZeneca S.p.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pricing & Health Economic Affairs Dept., AstraZeneca S.p.A., Basiglio, Mi, Italy","institution_ids":["https://openalex.org/I4210139728"]},{"raw_affiliation_string":"AstraZeneca S.p.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032116339"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00936442,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"1","first_page":"39","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.7724999785423279,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.7724999785423279,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.21559999883174896,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.765999972820282},{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9710000157356262},{"id":"https://openalex.org/keywords/salmeterol-fluticasone","display_name":"salmeterol/fluticasone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/maintenance-and-reliever-therapy","display_name":"maintenance and reliever therapy","score":0.953000009059906},{"id":"https://openalex.org/keywords/terbutaline","display_name":"terbutaline","score":0.6850000023841858},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.7940000295639038},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8220000267028809},{"id":"https://openalex.org/keywords/severe-asthma-exacerbation","display_name":"severe asthma exacerbation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/italian-national-health-service","display_name":"Italian National Health Service","score":0.6869999766349792},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7260000109672546},{"id":"https://openalex.org/keywords/beta-2-adrenergic-agonists","display_name":"beta2-adrenergic agonists","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8971817493438721},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.8808945417404175},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.8155186176300049},{"id":"https://openalex.org/C2781212218","wikidata":"https://www.wikidata.org/wiki/Q1002165","display_name":"Fluticasone","level":3,"score":0.6968289613723755},{"id":"https://openalex.org/C2776719499","wikidata":"https://www.wikidata.org/wiki/Q424333","display_name":"Salmeterol","level":3,"score":0.6128218770027161},{"id":"https://openalex.org/C2780252434","wikidata":"https://www.wikidata.org/wiki/Q424340","display_name":"Terbutaline","level":3,"score":0.5555647611618042},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.4709746837615967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24054181575775146}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/bf03320656","doi":"https://doi.org/10.1007/bf03320656","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf03320656","pdf_url":null,"source":{"id":"https://openalex.org/S2764875651","display_name":"PharmacoEconomics Italian Research Articles","issn_l":"1590-9158","issn":["1590-9158","2035-6137"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["anvur-scientific"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics Italian Research Articles","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W85469694","https://openalex.org/W144680332","https://openalex.org/W155335019","https://openalex.org/W376156748","https://openalex.org/W387031605","https://openalex.org/W1512398135","https://openalex.org/W1562415841","https://openalex.org/W1571272128","https://openalex.org/W1573656912","https://openalex.org/W1595046345","https://openalex.org/W1891620801","https://openalex.org/W1896805399","https://openalex.org/W1904593211","https://openalex.org/W1937705451","https://openalex.org/W1965021500","https://openalex.org/W1966407331","https://openalex.org/W1971883474","https://openalex.org/W1974042832","https://openalex.org/W1979098016","https://openalex.org/W1984462224","https://openalex.org/W2016541011","https://openalex.org/W2018803785","https://openalex.org/W2045200703","https://openalex.org/W2075484665","https://openalex.org/W2080649045","https://openalex.org/W2091408344","https://openalex.org/W2104305193","https://openalex.org/W2106203584","https://openalex.org/W2114800555","https://openalex.org/W2126502186","https://openalex.org/W2148583736","https://openalex.org/W2150106013","https://openalex.org/W2154146881","https://openalex.org/W2162451265","https://openalex.org/W2165143648","https://openalex.org/W2165209634","https://openalex.org/W2406468650","https://openalex.org/W2494251579","https://openalex.org/W2614452305","https://openalex.org/W2793094777","https://openalex.org/W3122426397","https://openalex.org/W3139856438","https://openalex.org/W3149712772","https://openalex.org/W4231008645","https://openalex.org/W4285719527","https://openalex.org/W4388330919"],"related_works":["https://openalex.org/W2135926399","https://openalex.org/W2273651304","https://openalex.org/W194760687","https://openalex.org/W4405810347","https://openalex.org/W2142605879","https://openalex.org/W2151038720","https://openalex.org/W1158400496","https://openalex.org/W2091408344","https://openalex.org/W2161722012","https://openalex.org/W2155712886"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}